5.655USD-3.08%Mkt Cap: 321.17M USDP/E: 5.93Last update: 2026-06-01
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy fo…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap321.17M USD
Enterprise Value184.33M USD
Revenue (TTM)14.54M USD
Gross Profit2.40M USD
Net Income (TTM)71.18M USD
Revenue/Share0.2660 USD
Last Price5.655 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees226
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)5.93
P/E (Forward)20.16
PEG—
EV/EBITDA-2.05
EV/Revenue12.68
P/S22.66
P/B2.27
EPS (TTM)0.95
EPS (Forward)0.29
52W Range
4.00047% of range7.540
52W High7.540 USD
52W Low4.000 USD
Profitability
Gross Margin41.15%
Oper. Margin-264.14%
EBITDA Margin0.00%
Profit Margin1223.08%
ROE44.71%
ROA32.42%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-76.33M USD
CapEx (TTM)7.97M USD
FCF Margin-389.20%
FCF Yield-17.62%
Net Debt-145.10M USD
Net Debt/EBITDA1.61
Balance Sheet
Debt/Equity0.16
Current Ratio5.89
Quick Ratio5.64
Book Value/Sh2.549 USD
Cash/Share2.952 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateJul 5, 2022
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)19.71 USD
Target Range14.00 USD – 28.00 USD
# Analysts7
Ownership
Shares Out.57.00M
Float36.34M
Insiders16.72%
Institutions70.54%
Short Interest
Short Ratio13.3d
Short % Float27.25%
Short % Out.25.38%
Shares Short14.47M
Short (prev mo.)16.47M
Technical
SMA 505.206 (+8.6%)
SMA 2005.337 (+6.0%)
Beta1.34
S&P 52W Chg27.94%
Avg Vol (30d)1.01M
Avg Vol (10d)1.04M
Technical Indicators
RSI (14)59.6
MACD0.0835
MACD Signal0.0789
MACD Hist.+0.0046
BB Upper6.117 USD
BB Middle5.639 USD
BB Lower5.162 USD
BB Width16.94%
ATR (14)0.2505 USD
Vol Ratio (20d)0.37x